LU68212A1 - - Google Patents

Info

Publication number
LU68212A1
LU68212A1 LU68212A LU68212DA LU68212A1 LU 68212 A1 LU68212 A1 LU 68212A1 LU 68212 A LU68212 A LU 68212A LU 68212D A LU68212D A LU 68212DA LU 68212 A1 LU68212 A1 LU 68212A1
Authority
LU
Luxembourg
Application number
LU68212A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU68212A1 publication Critical patent/LU68212A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/005Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/08Copper compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Steroid Compounds (AREA)
LU68212A 1972-08-11 1973-08-10 LU68212A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3765572A GB1440063A (en) 1972-08-11 1972-08-11 17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids

Publications (1)

Publication Number Publication Date
LU68212A1 true LU68212A1 (en:Method) 1973-10-16

Family

ID=10398029

Family Applications (1)

Application Number Title Priority Date Filing Date
LU68212A LU68212A1 (en:Method) 1972-08-11 1973-08-10

Country Status (16)

Country Link
US (1) US3891631A (en:Method)
JP (1) JPS5752359B2 (en:Method)
BE (1) BE803461A (en:Method)
CA (1) CA1027109A (en:Method)
CH (1) CH590884A5 (en:Method)
DE (1) DE2340591A1 (en:Method)
DK (1) DK135998B (en:Method)
ES (1) ES417738A1 (en:Method)
FR (1) FR2205508B1 (en:Method)
GB (1) GB1440063A (en:Method)
IE (1) IE38312B1 (en:Method)
IL (1) IL42942A (en:Method)
LU (1) LU68212A1 (en:Method)
NL (1) NL7311072A (en:Method)
SE (1) SE387951B (en:Method)
ZA (2) ZA735453B (en:Method)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000742A1 (de) * 1977-08-04 1979-02-21 Hoechst Aktiengesellschaft Corticoid-17-Alkylcarbonate und Verfahren zu deren Herstellung und diese enthaltende Mittel
EP0004975A3 (en) * 1978-04-25 1979-11-14 Hoechst Aktiengesellschaft 17-alkylcarbonates of corticoids, process for their preparation and their use as medicines against dermatoses
EP0136586A3 (en) * 1983-09-07 1986-01-29 Mitsubishi Chemical Industries Limited Novel corticoid derivatives and process for production thereof
FR2683820A1 (fr) * 1991-11-08 1993-05-21 Roussel Uclaf Nouveaux esters derives du 20-oxo 17alpha, 21-dihydroxy pregnane.

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1516095A (en) * 1974-07-31 1978-06-28 Glaxo Lab Ltd 17,21-diesters of 17alpha,21-dihydroxy-steroids of the pregnane series
GB1593978A (en) * 1976-12-31 1981-07-22 Lark Spa Anti-inflammatory steroids
US4086254A (en) * 1977-04-13 1978-04-25 The Upjohn Company Photocleavable steroids
DE2759135A1 (de) * 1977-12-30 1979-07-19 Lark Spa Neue steroidverbindungen und deren herstellung und verwendung
DE3133082A1 (de) 1981-08-18 1983-03-10 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue hydrocortison-derivate, ihre herstellung und verwendung
DE3637806A1 (de) * 1986-11-06 1988-05-19 Hoechst Ag Verfahren zur herstellung von prednisolon-17-ethylcarbonat durch umlagerung von prednisolon-21-ethylcarbonat
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
EP1305329B2 (en) * 2000-08-05 2015-03-18 Glaxo Group Limited 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
EP2039700A2 (en) * 2001-04-30 2009-03-25 Glaxo Group Limited Novel anti-inflammatory androstane derivatives
AU2002356759A1 (en) * 2001-12-01 2003-06-17 Glaxo Group Limited 17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
US8207151B2 (en) 2008-05-28 2012-06-26 Validus Biopharma Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
WO2017004205A1 (en) 2015-06-29 2017-01-05 Reveragen Biopharma, Inc. NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3255218A (en) * 1962-03-28 1966-06-07 Schering Corp 17(20)-enol-21-aldehydes of the pregnane series
US3780177A (en) * 1967-06-16 1973-12-18 Warner Lambert Co 17-butyrate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
IT1034011B (it) * 1969-06-26 1979-09-10 Vister Vismara Terapeutici S P Processo per la prapratzione di 17 monoesteri di 17 a 21 diossisteroidi per idrolisi die corpispondenti 17 21 ortoesteri ciclici a ph control lato

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000742A1 (de) * 1977-08-04 1979-02-21 Hoechst Aktiengesellschaft Corticoid-17-Alkylcarbonate und Verfahren zu deren Herstellung und diese enthaltende Mittel
EP0004975A3 (en) * 1978-04-25 1979-11-14 Hoechst Aktiengesellschaft 17-alkylcarbonates of corticoids, process for their preparation and their use as medicines against dermatoses
EP0136586A3 (en) * 1983-09-07 1986-01-29 Mitsubishi Chemical Industries Limited Novel corticoid derivatives and process for production thereof
FR2683820A1 (fr) * 1991-11-08 1993-05-21 Roussel Uclaf Nouveaux esters derives du 20-oxo 17alpha, 21-dihydroxy pregnane.
EP0546875A3 (en) * 1991-11-08 1994-05-18 Roussel Uclaf New process for the preparation of 20-oxo, 17-alpha, 21-dihydroxy derivatives of pregnane and new intermediates thereof
CN1036719C (zh) * 1991-11-08 1997-12-17 鲁索-艾克勒夫公司 制备孕烷的20-氧代-17α,21-二羟基衍生物的方法

Also Published As

Publication number Publication date
DK135998B (da) 1977-07-25
ES417738A1 (es) 1976-06-16
IE38312L (en) 1974-02-11
IL42942A0 (en) 1973-11-28
AU5914373A (en) 1975-02-13
ZA735452B (en) 1974-07-31
IE38312B1 (en) 1978-02-15
BE803461A (fr) 1974-02-11
CH590884A5 (en:Method) 1977-08-31
GB1440063A (en) 1976-06-23
JPS5752359B2 (en:Method) 1982-11-06
US3891631A (en) 1975-06-24
FR2205508A1 (en:Method) 1974-05-31
JPS4985062A (en:Method) 1974-08-15
SE387951B (sv) 1976-09-20
NL7311072A (en:Method) 1974-02-13
ZA735453B (en) 1974-10-30
CA1027109A (en) 1978-02-28
DE2340591A1 (de) 1974-03-07
FR2205508B1 (en:Method) 1978-09-15
IL42942A (en) 1977-05-31
DK135998C (en:Method) 1977-12-27

Similar Documents

Publication Publication Date Title
FR2179904A1 (en:Method)
DK135998C (en:Method)
JPS5761028B2 (en:Method)
FR2195300A5 (en:Method)
JPS4927274A (en:Method)
NO133213C (en:Method)
JPS4923076A (en:Method)
JPS5538790B2 (en:Method)
JPS5036773Y2 (en:Method)
JPS5411535Y2 (en:Method)
CS156045B1 (en:Method)
CS155034B1 (en:Method)
CS157559B1 (en:Method)
CS152732B1 (en:Method)
CS157943B1 (en:Method)
JPS493079A (en:Method)
RO60270A2 (en:Method)
CS156836B1 (en:Method)
JPS4986074U (en:Method)
CS157295B1 (en:Method)
JPS4912268U (en:Method)
CS157328B1 (en:Method)
CS157408B1 (en:Method)
CS157414B1 (en:Method)
CS158020B1 (en:Method)